Trials / Unknown
UnknownNCT04961138
Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma
Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma: an Open, Random, Multicenter, Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 164 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of present study is to evaluate whether per-operative neoadjuvant therapy combined with surgery could improve the 1-year disease-free survival of stage III hepatocellular carcinoma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transhepatic Arterial Chemotherapy And Embolization (TACE) | Receiving TACE and lenvatinib before surgery. |
| PROCEDURE | Surgery | Removing tumor by surgery. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-12-01
- Completion
- 2023-03-01
- First posted
- 2021-07-14
- Last updated
- 2021-07-14
Source: ClinicalTrials.gov record NCT04961138. Inclusion in this directory is not an endorsement.